News Minimalist logo

EU rejects Alzheimer's drug lecanemab over safety concerns

bbc.com — July 26, 2024, 06:00 PM UTC

Summary: The European Medicines Agency (EMA) has rejected lecanemab, an Alzheimer’s drug, citing that its benefits do not outweigh the risks of serious side effects, including brain bleeding and swelling. Lecanemab, approved in the U.S. earlier this year, showed a 25% reduction in cognitive decline in early-stage patients. The UK’s MHRA is still reviewing the drug, with a decision expected soon.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [4.8]
    EMA approves 14 medicines, rejects Alzheimer’s drug Leqembi (EURACTIV)
    49d 1h
    Source
  2. [3.6]
    CervoMed presents promising DLB biomarker data at AAIC 2024 (globenewswire.com)
    49d 5h
    Source
  3. [3.9]
    Anavex's drug slowed cognitive decline in early Alzheimer's trial (seekingalpha.com)
    49d 14h
    Source
  4. [4.4]
    Eisai shares drop 12% after EU rejects Alzheimer’s drug (news.yahoo.com)
    49d 16h
    Source
  5. [3.8]
    Blarcamesine significantly slows Alzheimer's decline, safe for patients (globenewswire.com)
    49d 20h
    Source
  6. [3.1]
    EU rejects Alzheimer's drug lecanemab over serious side effects (thesun.co.uk)
    52d 1h
    Source
  7. [5.4]
    EMA rejects Alzheimer’s drug Leqembi over safety concerns (Financial Times)
    52d 3h

    ScoresSource
  8. [4.3]
    European regulator rejects Alzheimer's drug Leqembi due to risks (cnbc.com)
    52d 4h
    Source
  9. [3.3]
    Eisai to request re-examination of lecanemab's negative CHMP opinion (prnewswire.com)
    52d 5h
    Source
  10. [3.5]
    European regulators issue negative opinion on lecanemab approval (globenewswire.com)
    52d 6h
    Source
  11. [3.5]
    CHMP issues negative opinion on lecanemab for Alzheimer's treatment (prnewswire.com)
    52d 6h
    Source